Epsilon M&A Deal Report - Omnigroup (Omnipharm and B-Pharma Laboratoire)
Transaction Multiples for the Valuation of Private Companies
Private Group led by Merieux Equity Partners / Omnigroup (Omnipharm and B-Pharma Laboratoire)
No EMAT :
95276
Announced Date :
18/12/2018
Type :
LBO (Leverage Buy Out)
Deal Value :
Yes
Acquirer :
Private Group led by Merieux Equity Partners
Target :
Omnigroup (Omnipharm and B-Pharma Laboratoire)
Country :
Savoie
Sector of activity :
- Food Producers > Food & Beverage Industry > Food Complements
Business Description :
Founded in 2008, OMNIGROUP (the holding company) is a reference player in the food ingredient market, focusing on the supply, formulation and manufacturing of food supplements , with two main...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Food Complements » = 122
| Date | Acquirer | Target | Country | Multiples | See details |
| 10/01/2018 | Dermapharm | Trommsdorff | Germany | *** | 95078 |
| 29/05/2019 | Groupe Lactalis | Nuova Castelli | Italy | ** | 95001 |
Source: Epsilon Research / EMAT
